Loading...
The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet
Dolutegravir 50 mg (DTG) and rilpivirine 25 mg (RPV) are a newly approved 2-drug regimen for the treatment of HIV in virally suppressed patients. A 2-part study evaluated the relative bioavailability and food effect of five experimental fixed-dose combination (FDC) tablet formulations of DTG/RPV. Wh...
Na minha lista:
| Udgivet i: | Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7292371/ https://ncbi.nlm.nih.gov/pubmed/32607002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S250751 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|